Allogeneic NK cells with a bispecific innate cell engager in refractory relapsed lymphoma: a phase 1 trial
The University of Texas MD Anderson Cancer Center · Affimed Therapeutics (Germany)
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
47
total citations
- FWCI
- 28.45
- Percentile
- 100%
- References
- 32
Citations per year
Authors
36- YNYago NietoCorresponding
The University of Texas MD Anderson Cancer Center
- PPPinaki P. Banerjee
The University of Texas MD Anderson Cancer Center
- IKIndreshpal Kaur
The University of Texas MD Anderson Cancer Center
- RBRafet Başar
The University of Texas MD Anderson Cancer Center
- YLYe Li
The University of Texas MD Anderson Cancer Center
Topics & keywords
Topics
Keywords
- Refractory (planetary science)
- Cancer research
- Lymphoma
- Medicine
- Immunology
- Biology
UN Sustainable Development Goals
- Zero hunger
No related works found for this paper.